Graf Akcie HALO (Halozyme Therapeutics Inc.). Diskuze k akciím HALO. Aktuální informace HALO.

Základní informace o společnosti Halozyme Therapeutics Inc. (Akcie HALO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 5.47B
Hodnota podniku (EV) 5.98B
Tržby 412.496M
EBITDA 264.781M
Zisk 228.724M
Růst v tržbách Q/Q 147.11 %
Růst v tržbách Y/Y 128.57 %
P/E (Cena vůči ziskům) 22.88
Forward P/E 21.44
EV/Sales 14.50
EV/EBITDA 22.58
EV/EBIT 24.62
PEG 0.69
Price/Sales 13.26
P/FCF 36.51
Price/Book 36.22
Účetní hodnota na akcii 1.04
Hotovost na akcii 2.54
FCF vůči ceně 2.74 %
Počet zaměstnanců 136
Tržba na zaměstnance 3033000
Profit margin 48.24 %
Operating margin 63.44 %
Gross margin 83.79 %
EBIT margin 58.88 %
EBITDA margin 64.19 %
EPS - Zisk na akcii 1.65
EPS - Kvartální růst 226.32 %
EPS - Očekávaný růst příští rok 68.00 %
Return on assets 29.55 %
Return on equity 209.18 %
ROIC 26.13 %
ROCE 26.64 %
Dluhy/Equity 2.84
Čistý dluh/EBITDA 1.14
Current ratio 8.75
Quick Ratio 8.24
Volatilita 3.39
Beta 1.42
RSI 40.28
Cílová cena analytiků 40
Známka akcie (dle analytiků) 1.40
Insider ownership 1.03 %
Institutional ownership 95.68 %
Počet akcií 142.335M
Procento shortovaných akcií 5.28 %
Short ratio 6.17 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2004
Země United States

Finanční výsledky akcie HALO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$267.594$195.992$151.862$316.613$146.691$135.057
Cost Of Goods Sold$43.367$45.546$10.136$31.152$33.206$29.245
Gross Profit$224.227$150.446$141.726$285.461$113.485$105.812
Research And Development Expenses$34.236$140.804$150.252$150.643$150.842$93.236
SG&A Expenses$45.736$77.252$60.804$53.816$45.853$40.028
Other Operating Income Or Expenses------
Operating Expenses$123.339$263.602$221.192$235.611$229.901$162.509
Operating Income$144.255$-67.61$-69.33$81.002$-83.21$-27.452
Total Non-Operating Income/Expense$-14.953$-4.641$-10.463$-19.392$-18.651$-4.779
Pre-Tax Income$129.302$-72.251$-79.793$61.61$-101.861$-32.231
Income Taxes$0.217$-0.011$0.537$-1.361$1.162-
Income After Taxes$129.085$-72.24$-80.33$62.971$-103.023$-32.231
Other Income------
Income From Continuous Operations$129.085$-72.24$-80.33$62.971$-103.023$-32.231
Income From Discontinued Operations------
Net Income$129.085$-72.24$-80.33$62.971$-103.023$-32.231
EBITDA$162.514$-63.527$-68.487$84.621$-67.616$-25.775
EBIT$144.255$-67.61$-69.33$81.002$-83.21$-27.452
Basic Shares Outstanding136144144136128127
Shares Outstanding141144144139128127
Basic EPS$0.95$-0.50$-0.56$0.46$-0.81$-0.25
EPS - Earnings Per Share$0.91$-0.50$-0.56$0.45$-0.81$-0.25
# 2020 2019 2018 2017 2016 2015
Current Ratio1.31656.34582.86453.88624.69972.7502
Long-term Debt / Capital-0.80670.12290.37521.19480.3941
Debt/Equity Ratio2.62984.38720.50780.9711-6.66921.1589
Gross Margin83.793776.761393.325590.160977.363378.3462
Operating Margin53.9082-34.4963-45.653325.5839-56.7247-20.3262
EBIT Margin53.9082-34.4963-45.653325.5839-56.7247-20.3262
EBITDA Margin60.7316-32.4131-45.098226.727-46.0942-19.0845
Pre-Tax Profit Margin48.3202-36.8643-52.543119.4591-69.4392-23.8647
Net Profit Margin48.2391-36.8587-52.896719.889-70.2313-23.8647
Asset Turnover0.46140.34640.34490.60890.56090.7429
Inventory Turnover Ratio0.71391.55130.4486.05362.27083.082
Receiveable Turnover2.73813.29725.061214.3059.35534.1671
Days Sales In Receivables133.3044110.700172.11725.515539.015487.5901
ROE - Return On Equity85.4602-78.7228-32.275730.2213317.1795-74.9576
Return On Tangible Equity85.4602-78.7228-32.275730.2213317.1794-74.9575
ROA - Return On Assets22.259-12.7661-18.246512.1111-39.3947-17.7299
ROI - Return On Investment85.4602-15.2145-28.30918.8815-61.784-45.415
Book Value Per Share1.11860.67121.71971.4593-0.25080.3355
Operating Cash Flow Per Share0.9839-0.2472-1.30861.3576-0.1010.0946
Free Cash Flow Per Share1.0018-0.2427-1.33141.3724-0.10690.0872